<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Han J</submitter><funding>National Health and Medical Research Council</funding><pagination>108</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11763000</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The increasing prevalence of drug-resistant tuberculosis (TB) underscores the urgent need for novel antimicrobial agents.&lt;h4>Methods&lt;/h4>This study integrates cultivation optimization, nuclear magnetic resonance (NMR) fingerprinting, and principal component analysis (PCA) to explore microbial secondary metabolites as potential anti-TB agents.&lt;h4>Results&lt;/h4>Using the combined approach, 11 bioactive compounds were isolated and identified, all exhibiting anti-&lt;i>Mycobacterium bovis&lt;/i> BCG activity. Notable findings include borrelidin, a potent threonyl-tRNA synthetase inhibitor with broad biological activities, and L-O-Lac-L-Val-D-O-Hiv-D-Val, a peptide isolated for the first time from a plant endophyte, demonstrating broad-spectrum antimicrobial activity. Additionally, e</pubmed_abstract><journal>Antibiotics (Basel, Switzerland)</journal><pubmed_title>Nuclear Magnetic Resonance Fingerprinting and Principal Component Analysis Strategies Lead to Anti-Tuberculosis Natural Product Discovery from Actinomycetes.</pubmed_title><pmcid>PMC11763000</pmcid><funding_grant_id>2017517</funding_grant_id><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Liu M</pubmed_authors><pubmed_authors>Quinn RJ</pubmed_authors><pubmed_authors>Han J</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Nuclear Magnetic Resonance Fingerprinting and Principal Component Analysis Strategies Lead to Anti-Tuberculosis Natural Product Discovery from Actinomycetes.</name><description>&lt;h4>Background&lt;/h4>The increasing prevalence of drug-resistant tuberculosis (TB) underscores the urgent need for novel antimicrobial agents.&lt;h4>Methods&lt;/h4>This study integrates cultivation optimization, nuclear magnetic resonance (NMR) fingerprinting, and principal component analysis (PCA) to explore microbial secondary metabolites as potential anti-TB agents.&lt;h4>Results&lt;/h4>Using the combined approach, 11 bioactive compounds were isolated and identified, all exhibiting anti-&lt;i>Mycobacterium bovis&lt;/i> BCG activity. Notable findings include borrelidin, a potent threonyl-tRNA synthetase inhibitor with broad biological activities, and L-O-Lac-L-Val-D-O-Hiv-D-Val, a peptide isolated for the first time from a plant endophyte, demonstrating broad-spectrum antimicrobial activity. Additionally, e</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2025-04-04T22:06:57.822Z</modification><creation>2025-04-04T22:06:57.822Z</creation></dates><accession>S-EPMC11763000</accession><cross_references><pubmed>39858393</pubmed><doi>10.3390/antibiotics14010108</doi></cross_references></HashMap>